inward rectifier potassium channel 2

from mouse brain (MB); amino acid sequence given in first source; GenBank X80417

Also Known As:

IRK2; MB-IRK2

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Carrier Proteins: 12999
    - Membrane Transport Proteins: 589
      - Ion Channels: 6731
        Potassium Channels: 2882
        Inwardly Rectifying Potassium Channels: 176
        inward rectifier potassium channel 2: 2
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Ion Channels: 6731
        Potassium Channels: 2882
        Inwardly Rectifying Potassium Channels: 176
        inward rectifier potassium channel 2: 2
    - Membrane Transport Proteins: 589
      - Ion Channels: 6731
        Potassium Channels: 2882
        Inwardly Rectifying Potassium Channels: 176
        inward rectifier potassium channel 2: 2

Experts

1.	Ishikawa, Hiroshi: 1 article (11/2021)
2.	Mizuguchi, Maki: 1 article (11/2021)
3.	Mori, Keita: 1 article (11/2021)
4.	Nagashima, Takeshi: 1 article (11/2021)
5.	Notsu, Akifumi: 1 article (11/2021)
6.	Ohde, Yasuhisa: 1 article (11/2021)
7.	Ohnami, Sumiko: 1 article (11/2021)
8.	Sato, Junya: 1 article (11/2021)
9.	Sato, Tetsu: 1 article (11/2021)
10.	Sato, Tetsumi: 1 article (11/2021)

Related Diseases

1.	Urinary Retention 11/05/2021 - "Incidence rates for 6 adverse effects of opioid therapy (somnolence, nausea, constipation, delirium, urinary retention, and pruritus) were determined and the influence of single nucleotide polymorphisms in coding regions of the opioid μ receptor 1 (OPRM1) (rs1799971), opioid δ receptor 1 (rs2234918), opioid κ receptor 1 (rs1051660), catechol-O-methyltransferase (COMT) (rs4680), dopamine receptor D2 (rs6275), adenosine triphosphate binding cassette B1 (rs1045642), G-protein regulated inward rectifier potassium channel 2 (rs2070995), and fatty acid amide hydrolase (rs324420) genes on those adverse effects were analyzed.Analysis"
2.	Pruritus (Itching) 11/05/2021 - "Incidence rates for 6 adverse effects of opioid therapy (somnolence, nausea, constipation, delirium, urinary retention, and pruritus) were determined and the influence of single nucleotide polymorphisms in coding regions of the opioid μ receptor 1 (OPRM1) (rs1799971), opioid δ receptor 1 (rs2234918), opioid κ receptor 1 (rs1051660), catechol-O-methyltransferase (COMT) (rs4680), dopamine receptor D2 (rs6275), adenosine triphosphate binding cassette B1 (rs1045642), G-protein regulated inward rectifier potassium channel 2 (rs2070995), and fatty acid amide hydrolase (rs324420) genes on those adverse effects were analyzed.Analysis"
3.	Nausea 11/05/2021 - "Incidence rates for 6 adverse effects of opioid therapy (somnolence, nausea, constipation, delirium, urinary retention, and pruritus) were determined and the influence of single nucleotide polymorphisms in coding regions of the opioid μ receptor 1 (OPRM1) (rs1799971), opioid δ receptor 1 (rs2234918), opioid κ receptor 1 (rs1051660), catechol-O-methyltransferase (COMT) (rs4680), dopamine receptor D2 (rs6275), adenosine triphosphate binding cassette B1 (rs1045642), G-protein regulated inward rectifier potassium channel 2 (rs2070995), and fatty acid amide hydrolase (rs324420) genes on those adverse effects were analyzed.Analysis"
4.	Delirium 11/05/2021 - "Incidence rates for 6 adverse effects of opioid therapy (somnolence, nausea, constipation, delirium, urinary retention, and pruritus) were determined and the influence of single nucleotide polymorphisms in coding regions of the opioid μ receptor 1 (OPRM1) (rs1799971), opioid δ receptor 1 (rs2234918), opioid κ receptor 1 (rs1051660), catechol-O-methyltransferase (COMT) (rs4680), dopamine receptor D2 (rs6275), adenosine triphosphate binding cassette B1 (rs1045642), G-protein regulated inward rectifier potassium channel 2 (rs2070995), and fatty acid amide hydrolase (rs324420) genes on those adverse effects were analyzed.Analysis"
5.	Constipation 11/05/2021 - "Incidence rates for 6 adverse effects of opioid therapy (somnolence, nausea, constipation, delirium, urinary retention, and pruritus) were determined and the influence of single nucleotide polymorphisms in coding regions of the opioid μ receptor 1 (OPRM1) (rs1799971), opioid δ receptor 1 (rs2234918), opioid κ receptor 1 (rs1051660), catechol-O-methyltransferase (COMT) (rs4680), dopamine receptor D2 (rs6275), adenosine triphosphate binding cassette B1 (rs1045642), G-protein regulated inward rectifier potassium channel 2 (rs2070995), and fatty acid amide hydrolase (rs324420) genes on those adverse effects were analyzed.Analysis"

Related Drugs and Biologics

1.	GTP-Binding Proteins (G-Protein)
2.	Potassium Channels (Potassium Channel)
3.	Dopamine Receptors (Dopamine Receptor)
4.	Proteins (Proteins, Gene)
5.	Microfilament Proteins (Actin Binding Proteins)
6.	Catechol O-Methyltransferase (Methyltransferase, Catechol)
7.	Opioid Analgesics (Opioids)
8.	Adenosine Triphosphate (ATP)
9.	fatty-acid amide hydrolase (fatty acid amide hydrolase)

Related Therapies and Procedures

1.	Therapeutics